Rothblatt Martine A

Chairperson &CEO

1 company

Good

Trades Analyzed

296

12M Win Rate

53.6%

Avg 3M Return

-6.6%

Avg 12M Return

-1.6%

Rothblatt Martine A is a Chairperson &CEO at UNITED THERAPEUTICS Corp. Recent SEC Form 4 filings include 0 buys and 52 sells.

Estimated insider holdings value: $26.6M based on current market prices.

Holdings by Company

UTHRApr 20, 2026

Current Shares46.8K

Value$26.63M

Net Activity-320,269

Bought: 0Sold: 320.3K

Showing 10 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 10, 2025	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	8,000	$479.17	$3,833,374.18	-50.8%	+10.6%	-
Dec 8, 2025	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	8,000	$483.76	$3,870,056.43	-49.1%	+10.4%	-
Dec 4, 2025	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	8,000	$477.64	$3,821,130.43	-52.0%	+1.3%	-
Dec 2, 2025	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	8,000	$481.61	$3,852,845.94	-39.6%	+8.4%	-
Nov 28, 2025	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	8,866	$486.13	$4,310,041.79	-49.4%	+3.8%	-
Sep 24, 2025	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	8,000	$426.14	$3,409,081.18	-71.4%	+16.3%	-
Sep 22, 2025	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	8,000	$414.19	$3,313,522.60	-77.0%	+23.9%	-
Sep 18, 2025	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	8,000	$402.29	$3,218,352.01	-64.5%	+24.7%	-
Sep 16, 2025	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	4,000	$400.27	$1,601,062.10	-55.1%	+25.7%	-
Sep 15, 2025	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	8,000	$400.93	$3,207,435.64	-52.9%	+24.1%	-